Figure 2.
Aggregation of indomethacin-treated human platelet-rich plasma induced by prostaglandin endoperoxide (PGG2) and by thromboxane A2 (TXA2). TXA2 is far more potent than PGG2.
Aggregation of indomethacin-treated human platelet-rich plasma induced by prostaglandin endoperoxide (PGG2) and by thromboxane A2 (TXA2). TXA2 is far more potent than PGG2.